Denator Strengthens Commercial Management
News Oct 15, 2013
Denator AB has confirmed the expansion of the company's management team through the appointment of Karsten Fjärstedt as Vice President for Global Sales and Marketing.
In his role as vice president, Karsten will provide strategic vision and direction for all sales and marketing activities. Karsten has over 24 years of experience from the biotech and pharmaceutical industry and is joining from GE Healthcare Life Sciences where he has held senior executive management positions over the past 10 years.
I am very excited to join Denator", Karsten comments, "The company has a unique technology which I think has a great potential of expanding into many different market segments. By strengthening our strategic marketing efforts, we expect to increase the pace of introducing the technology to the wider market place.”
Olof Sköld, CEO at Denator, states: "I am very pleased to announce the appointment of Karsten as VP for Global sales and marketing. With his extensive experience and track record he will significantly strengthen our company."
Researchers have developed an artificial enzymatic pathway for synthesizing isoprenoids, or terpenes, in E. coli. This shorter, more efficient, cost-effective and customizable pathway transforms E. coli into a factory that can produce terpenes for use in everything from cancer drugs to biofuels.READ MORE
UT Southwestern researchers have succeeded in neutralizing what they believe is a primary factor in late-onset Alzheimer’s disease, opening the door to development of a drug that could be administered before age 40, and taken for life, to potentially prevent the disease in 50 to 80 percent of at-risk adults.READ MORE
2nd International Conference on Pharmaceutical Research & Innovations in Pharma Industry
May 30 - May 31, 2019
3rd Annual DIGI-TECH PHARMA 2019 Conference & Expo
May 21 - May 22, 2019